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Abstract: 
Background: Fatigue is one of the most distressing and commonly experienced symptoms in 
patients with advanced cancer. Although the self-management (SM) of cancer-related 
symptoms has received increasing attention, no research instrument assessing fatigue SM 
outcomes for patients with advanced cancer is available.  
Objectives: to describe the development and preliminary testing of an interviewer-
administered instrument for assessing the frequency, and perceived levels of effectiveness 
and self-efficacy associated with fatigue SM behaviors in patients with advanced cancer. 
Methods: The development and testing of the Self-efficacy in Managing Symptoms Scale- 
Fatigue Subscale for Patients with Advanced Cancer (SMSFS-A) involved a number of 
procedures: item-generation using a comprehensive literature review and semi-structured 
interviews, content validity evaluation using expert panel reviews, and face validity and test-
retest reliability evaluation using pilot testing. 
Results: Initially, 23 items (22 specific behaviors with one global item) were generated from 
the literature review and semi-structured interviews. After two rounds of expert panel review, 
the final scale was reduced to 17 items (16 behaviors with one global item). Participants in 
the pilot test (n=10) confirmed that the questions in this scale were clear and easy to 
understand. Bland-Altman analysis showed agreement of results over a one-week interval. 
Conclusions: The SMSFS-A items were generated using multiple sources. This tool 
demonstrated preliminary validity and reliability. 
Implications for practice: The SMSFS-A has the potential to be used for clinical and research 
purposes. Nurses can use this instrument for collecting data to inform the initiation of 
appropriate fatigue SM support for this population. 
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Introduction 
The importance of self-management (SM) as a health care model is increasingly recognised in 
caring for people with chronic conditions. The National Cancer Research Institute in the UK 
proposed that SM research is a key area for the innovative approaches to address complex 
symptoms, including non-pharmacological approaches to symptom management.1 In SM 
models, health professionals focus on what they, the caregivers and the health system can do 
to enable the patient to care their own condition.  
 
Self-efficacy theory has often been used in recent cancer care research as a framework to 
explain behavioural responses to cancer2-6. For example, Porter cross-sectionally surveyed 30 
patients with newly diagnosed lung cancer, reporting that patients with higher level of 
perceived self-efficacy in managing their symptoms had lower symptom severity, including 
pain2. Other recent work undertaken by Liang and colleagues (2008) revealed the relationship 
between opioid-taking perceived self-efficacy and opioid taking adherence and pain levels 
amongst patients with cancer3-5. Other research evidence suggests that perceived self-efficacy  
is a valuable construct that can explain the level of pain5, 6, pain behaviors5, levels of fatigue6, 
and symptom experiences6 of patients with cancer.  The purpose of this study is to describe the 
development of an instrument to measure self-efficacy associated with SM behaviors 
associated cancer-related fatigue. 
 
Cancer-related fatigue (CRF) is one of the most frequently experienced and distressing 
symptoms reported by cancer patients.7, 8 The management of CRF is complex and often 
involves a combination of pharmacological and non-pharmacological strategies. Regardless of 
which strategies are used, most of these management strategies require behavioral responses 
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on the part of the patient (e.g. maintaining sleep hygiene, exercise and energy conservation). 
There are ongoing research efforts to provide an evidence base to support the use of these 
strategies both individually (e.g. exercise interventions alone) or in combination (e.g. a 
behavioral interventions involving a number of strategies). The behaviors required to manage 
fatigue can involve a collaborative effort between patients and health professionals (e.g. 
through taking prescribed medications), or can be self-initiated without any prompting by their 
health professionals (e.g. through engaging in behavioral strategies such as modifying their 
diet).   
 
Some research has been undertaken to explore self-management behaviours for managing 
fatigue in patients with cancer undergoing active treatment with curative intent9-11, there is 
however a lack of information concerning such issues in patients with advanced disease12. 
Fatigue in patients with advanced cancer can potentially have quite different aetiologies 
compared to patients at earlier stages of their disease. As their disease progresses, they can also 
experience reduced cognition and functional status that impedes their ability to self-manage. 
To date, there has been limited evidence regarding the behaviours patients with advanced 
cancer perform in managing fatigue and the effectiveness of those behaviours from the patient’s 
perspective. Gaining a deeper understanding of such behaviours in this patient group will assist 
with the design of appropriate patient-centred interventions for this population13. 
 
Although a number of CRF measurements are available in the literature,14-17 these 
measurements focus on the intensity and interference or distress levels of fatigue. A 
comprehensive instrument to assess various components of SM behaviors is not available. The 
issues associated with SM support are complex. For effective SM support and measurement to 
occur, health professionals must understand the patient’s perspective,18 as well as accurately 
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evaluate the SM outcomes of their intervention. In particular, Dodd et al. suggested several 
practical issues that are critical to effective SM support and measurement.18 These issues 
include, but are not limited to: What behaviors do patients choose to engage in? When and how 
often do they engage in them? Are the behaviors effective or ineffective from the patient’s 
perspective (if effective, to what extent)? What are the perceived self-efficacy  levels of patients 
as they attempt to manage their health issue (i.e. fatigue)?  
 
This study aimed to develop an instrument entitled the Self-efficacy in Managing Symptoms 
Scale- Fatigue Subscale for Patients with Advanced Cancer (SMSFS-A) which evaluates the 
level of perceived self-efficacy, the frequency and the perceived effectiveness of fatigue 
management strategies from the perspective of patients with advanced cancer.19, 20  
 
Theoretical Framework 
Perceived self-efficacy is a social-cognitive theoretical construct, that was first conceptualized 
by Bandura in 1977.21 The strength of perceived self-efficacy refers to judgment of how certain 
one is of one’s ability to perform a specific task in these situations.21 Bandura proposed that 
Social Cognitive Theory views human functioning as determined by the dynamic interaction 
of personal, behavioral, and environmental influences.22, 23 Given that such personal, 
environmental and behavioral factors are often amenable to intervention, a person’s behavior 
can change. Bandura further suggests that outcome expectations in SM are based largely on 
the individual’s self-efficacy expectations.22, 23 The outcomes people anticipate generally 
depend on their judgments of how well they will be able to perform the behavior. Social 
cognitive theory purports that the higher the individual’s efficacy-expectation levels towards a 
particular behavior, the greater will they have to succeed in achieving a task.22, 23 While people 
might believe that they can achieve tasks, people still cannot perform tasks beyond their 
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abilities.24 People with higher perceived self-efficacy believe they can take action to solve a 
problem, and they are more committed to their actions.24 In contrast, people with lower 
perceived self-efficacy expectations are less likely to take action to solve a problem.24 
According to Bandura (1998), understanding the factors influencing a person’s behavior is 
required to overcome the impediments to new lifestyle choices.25 
 
Methods 
The development of the SMSFS-A was part of a study that aimed to examine fatigue SM 
behaviors in patients with advanced cancer and the factors influencing these behaviors26. This 
part of the study was conducted in three phases: (1) item generation using data from a 
comprehensive literature review and semi-structured interviews, (2) content validity evaluation 
using expert panel reviews and (3) feasibility evaluation of an instrument assessing SM 
behaviors associated with fatigue in patients with advanced cancer. “Ethics approvals were 
granted by the Royal Brisbane and Women’s Hospital and the Queensland University of Technology 
University Human Research Ethics Committees. 
 
Concerning the construction of self-efficacy scales, Bandura argued that one cannot be all 
things.27 People have different levels of efficacy in different situations; their efficacy belief 
system is not a global trait. To serve the purpose of a specific scale, items should therefore not 
be expressed in general terms, which creates ambiguity about exactly what is being measured. 
According to Bandura27, items for measuring perceived self-efficacy should focus on specific 
situations and outcome expectations. For example, “When you have other time commitments, 
how certain you are that you can get yourself to perform your exercise routine regularly?”  The 
management of cancer-related fatigue involves a wide variety of behaviors. It may include 
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exercise, managing eating habits, resting, energy conservation, relaxation,.28 Therefore, the 
SMSFS-A couched all questions in the context of advanced cancer.  
 
Semi-structured interviews 
During the first phase of tool development, semi-structured interviews were conducted 
to scope the range of activities patients with advanced cancer undertake to self-manage their 
fatigue. Participants were recruited from the largest tertiary cancer care centre in Queensland, 
Australia. The sampling frame for this phase of the study was limited to all individuals 
diagnosed with advanced cancer who fulfilled the following recruitment criteria: diagnosed 
with at least one distant metastasis; reported an average fatigue intensity score of 4 or above 
on a 0-10 numerical rating scale in the past 7 days; were over 18 years of age; were, in the 
opinion of the treating team, able to provide informed consent; had completed first-line therapy 
since the first diagnosis of cancer; and had a life expectancy of more than two months. Patients 
were excluded if they were, in the opinion of the treating team, unable to provide informed 
consent; were unable to speak and understand English; or were deemed by treating clinicians 
to be “too ill” or had “altered cognition” and not able to participate. 
 
The interview questions were guided by a question prompt-list that included a number of SM 
behaviors associated with fatigue as identified in the literature review. It was possible that 
patients performed these behaviors as general coping behaviors, and that they were not 
specifically for managing fatigue. Therefore, participants were asked specifically if they 
undertook certain behaviors to manage fatigue and whether it was useful for reducing it. Where 
any doubt arose, further prompts encouraged the participants to clarify whether their responses 
were specific to their management of fatigue, as opposed to general coping.  
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Sample size 
There are no universal rules that determine the sample size of qualitative studies.29, 30 Some 
qualitative studies use a data saturation method for determining the sample size, but its use is 
controversial.31 Marshall (1996) suggested that an appropriate sample size for a qualitative 
study is one that adequately answers the research question.31 Sandelowski (1995) argued that 
adequate sample size in qualitative research method is ultimately a matter of the judgement of 
the researcher, who is best placed to evaluate the quality of the information collected against 
the uses to which it will be put.32 For this reason, a convenience sample of ten patients with 
advanced cancer with a fatigue severity score of four or above was interviewed. 
 
Analysis of the semi-structured interviews 
The data obtained from the interviews were audio-recorded and transcribed. Data were 
managed with the use of the audio and transcribing functions of the NVivo software, and a 
number of manual coding procedures.33 Without sufficient current knowledge of SM behaviors 
in patients with advanced cancer, a content analysis was conducted to gain knowledge about 
what patients with advanced cancer do to manage fatigue.34 In this study, the analysis of data 
in this stage pragmatically focussed on generalizability (i.e. identifying codes representing 
patients’ SM behaviors), rather than identifying patterns (i.e. why patients perform certain 
behaviors).35 The procedures for content analysis in the study were guided by Johnson and 
LaMontagne.33  
 
Content validity assessment 
Content validity is a crucial factor in instrument development, in that it addresses whether items 
within an instrument adequately measure a desired domain of content.36, 37 To ensure the 
SMSFS-A had content validity in patients with advanced cancer; five experts were contacted 
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and asked if they would participate as expert panellists. Criteria for selection of the panellists 
included having: (i) a minimum education levels of Masters degree, (ii) a minimum three years 
of previous experience in cancer nursing, or previous experience with instrument development 
for the assessment of SM in patients with cancer. These criteria were consistent with the 
recommendations of Grant and Davis.36 A minimum number of three experts was used as 
advised by Lynn in using the Content Validity Index (CVI) method to assess content validity.37 
To enhance the accuracy, appropriateness, and relevance of the items in patients with advanced 
cancer, the panellists were asked to add, delete, or alter questions to further modify the 
instrument, as they felt were applicable to the context of SM associated with fatigue in this 
cohort. The evaluation also included suggestions for format, clarity of items and relevance of 
items. Items that did not achieve a CVI for item clarity of 1 were modified or deleted. 
 
Pilot test 
This pilot test aimed to assess the feasibility and the reproducibility of the instrument.38 The 
setting, sampling frame and participant recruitment procedures for this stage was the same as 
that for the semi-structured interviews. Feasibility was assessed by measuring the time needed 
to complete the assessment tool, and asking patients about their views on the clarity of the 
questions, whether they could understand all items, whether the questions were easy to answer, 
and what other SM behaviors they undertook for fatigue that were not yet included in the tool. 
Further adjustments of the items were then made according to the comments given by patients. 
After one week patients were contacted via the telephone to complete the questionnaire again, 
in order to examine the reproducibility of results. The one-week interval was chosen as 
recommended by Summers (1993), who argued that the second test should not be more than 
two weeks after the first test.39 This is to ensure that patients give a valid measurement in the 
second test without necessarily remembering the answers that were given during the first test. 
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After the first two phases of development, the revised SMSFS-A was piloted with a 
convenience sample of 10 participants. It was expected that a sample of 10 participants would 
provide a valid analysis of measurement error for the purpose of evaluating reproducibility. 
This analysis would estimate the mean error and its confidence interval. Without any 
knowledge about an a priori difference, or how big a difference in error constitutes too much 
error, no sample size could be estimated. 
 
Data analysis of the pilot test  
All analyses were conducted using SPSS version 17. For test-retest reliability, Bland and 
Altman’s measurement error calculation over a one-week interval (or within subject standard 
deviation) was calculated using the two main outcomes of the SMSFS-A (i.e. “the overall level 
of self-efficacy of SM for fatigue” and “the overall level of effectiveness of SM for fatigue”).40  
 
Results 
Phase 1. Item generation using data from a comprehensive literature review and semi-
structured interviews, and the format and scaling of the SMSFS-A 
Our comprehensive review of the current literature related to fatigue management in patients 
with advanced cancer was published elsewhere.28 A number of pharmacological and non-
pharmacologic management strategies (including exercise, sleep/rest, energy conservation, 
complementary therapies, and psychosocial interventions) were identified in this review.  
 
Ten patients with advanced cancer (five women and five men) from the largest tertiary cancer 
care center in Brisbane, Australia participated in the semi-structured interviews. The median 
age of the sample was 67 (range 44-81). These patients had diagnoses including cancers of the 
breast, lung, ovarian, prostate and head and neck. All ten patients had at least one distant 
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metastatic disease and had completed first-line treatments for their cancer. The educational 
levels of these patients varied from having completed primary schooling to having completed 
tertiary education. Table 1 provides a summary of the socio-demographic and medical/clinical 
characteristics of participants. 
 
Insert Table 1 about here. 
 
Nine categories of behaviors reflecting the core behaviors patients undertake for managing 
fatigue were identified; namely rest; managing medications; doing relaxing tasks; exercise; 
keeping busy; managing workload; optimising nutritional intake; keeping positive; and 
accepting help from others. A summary of categories (of behaviors) and coded actions 
(individual behaviors) is presented in Table 2.  
 
Insert Table 2 about here. 
 
 
Phase 2. Expert panel reviews: content validity evaluation 
Based on the results of the comprehensive literature review and the semi-structured interviews, 
the first draft of the SMSFS-A including 23 initial items (22 specific behaviors and one global 
item) was created.  
 
The format and scaling of the SMSFS-A 
The SMSFS-A was designed to assess three domains of SM associated with fatigue in patients 
with advanced cancer. For each item (SM behavior), three domains including the frequency of 
using the SM behavior, the perceived levels of effectiveness and the levels of perceived self-
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efficacy associated with the SM behaviors, are assessed. If the patient used the particular 
behavior in the previous seven days, they would subsequently be asked to rate the frequency, 
effectiveness and the confidence levels associated with the behavior. The word confidence was 
sued in the questionnaire as “self-efficacy” is not a commonly known word to patients. If the 
patient did not use the behavior in the previous week, the particular behavior was not assessed. 
This method is congruent with our previous work in assessing symptom SM in patients with 
cancer.41 
 
The scale of frequency was rated as 0 = not used at all, 1 = occasionally (once a twice a week), 
2 = often (3-4 times a week), 3 = very often (5-6 times a week) and 4 = all the time (7 times or 
more a week). The levels of effectiveness of the behaviors in relieving fatigue were rated from 
0 to 10, with “0” indicating “not at all effective” and “10” indicating “extremely effective”. For 
the measurement of perceived self-efficacy, individuals rated the strength of their belief in their 
ability to execute a series of items. A single-judgment format was selected for this instrument; 
whereby individuals could rate the strength of their perceived efficacy from “0” indicating “not 
confident at all” to “10” indicating “extremely confident” for every item in the scale. Each item 
in the scale was rated for the frequency of use, the levels of perceived effectiveness and the 
levels of perceived self-efficacy associated with the behavior.  
 
Other than specific SM behaviors, two additional questions assessed the global level of 
effectiveness of fatigue SM behaviors and the global level of confidence. These items were: 
“Overall, over the past 7 days, how would you rate your effectiveness in relieving your fatigue” 
(0 = not effective at all, 10 = extremely effective); and “Overall, over the past 7 days, how 
would you rate your confidence in managing fatigue” (0 = not confident at all, 10 = extremely 
confident).  
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Following the evaluation of the first expert panel review, one item was retained; 14 items were 
amended and two items were added. One of the expert panellists raised a safety concern 
regarding the inclusion of the item that elicited medication-related behaviors due to the lack of 
efficacy of most prescribed medications for managing fatigue at the time of the panel review. 
Although the SMSFS-A was designed to be a measurement tool rather than an educational tool 
that advises the use of any of the behaviors, it was suggested that some interviewees might 
misunderstand the purpose of the tool and adopt the included behaviors being assessed. 
Therefore, actions associated with taking medications were removed. Subsequently, the 
amended version of the SMSFS-A containing 18 items (17 behaviors and one global item) was 
sent to the expert panel for the second round of review as recommended by Lynn37. The final 
version of the SMSFS-A achieved a CVI of 1 for relevance. With the feedback of the expert 
panel regarding clarity of the items, one further item was removed; five were amended and 11 
were retained without further amendment. Therefore, the final tool contains 17 items (16 
specific behaviors with one global item) (see Table 3). 
 
Insert Table 3 about here. 
 
Phase 3. Pilot test: feasibility and test-retest reliability evaluation 
Ten patients with advanced cancer (nine women and one man) from the same tertiary cancer 
care center in Brisbane, Australia participated in the pilot test. The mean age of the sample was 
62.6 (SD= 9.1). At baseline, five of the participants were inpatients and five were outpatients. 
These patients had diagnoses including breast cancer and lung cancer. All ten patients had at 
least one distant metastasis and had completed first-line treatments for their cancer. The 
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educational levels of these patients varied from having completed primary schooling to having 
completed tertiary education. The mean Australian Karnofsky Performance Status (AKPS) for 
this sample was 74 (SD=18.38). The mean fatigue numerical analogue score on average over 
the past seven days was 5.6 (SD=1.71). Table 4 summarises the socio-demographic and 
medical/clinical characteristics of participants in the pilot test at baseline. 
 
The average time to complete the survey at Time 1 was 11 minutes (7.5 minutes for Time 2). 
Ten participants completed Time 1 surveys, and nine participants completed Time 2 surveys. 
One participant did not complete the Time two survey as she was too fatigued and was not able 
to concentrate. This participant did manage to answer two questions that asked “Overall, over 
the past 7 days, how would you rate your effectiveness in relieving your fatigue?” and “Overall, 
over the past 7 days, how would you rate your confidence in managing your fatigue?” No 
further adjustments of the items were made at this time according to the comments given by 
patients. 
 
The two main outcomes of the SMSFS-A (the self-perceived overall effectiveness levels and 
the overall self-efficacy levels for fatigue SM) were selected for the reproducibility analysis, 
one week apart. The Bland-Altman plots indicated agreement between initial and subsequent 
pilot test outcomes over a 1-week interval (see Figures 1 and 2). These preliminary results 
demonstrated acceptable agreement between the initial and follow up tests. 
 
Insert Figures 1 and 2 about here 
 
Discussion 
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The interview data from this study revealed that participants performed a range of SM 
behaviors to manage fatigue. The reported behaviors were broadly categorised into five groups 
of behaviors: activities, complementary and alternative therapies, cognitive, psychological, and 
nutrition. According to Bandura27, items for measuring perceived self-efficacy should focus on 
specific situations. These broad categories of behaviors associated with fatigue have been 
reported previously in our systematic review of the literature.28 It is also expected that 
understanding the factors influencing a person’s own behavior is required to overcome the 
impediments to form new lifestyle choices.25 The tool developed in this study allows for 
measurement of various factors influencing the lifestyle choices corresponding to these broad 
categories of behavior related to fatigue management in patients with advanced cancer. While 
it is a common belief that “nothing can be done” for managing fatigue in this patient group42, 
43, the findings suggest otherwise. Indeed, patients do engage in SM activities for their fatigue, 
even at advanced stages of their disease. Moreover, these findings confirm that patients with 
advanced disease often spontaneously engage in a number of behaviors with or without the 
prescription of the health professionals. 
 
Hoffman et al. published a series of studies evaluating how nurses can enhance perceived self-
efficacy and in turn optimize patient outcomes.44, 45 Hoffman et al. propose that patients with 
cancer make decisions about their care, which are decisions on what and how much they are 
going to use SM behaviors.44 For example, patients experiencing CRF make decisions on how 
long to rest, whether to exercise and the extent to which they would carry out other prescribed 
interventions to manage fatigue.44 Different individuals have different levels of perceived 
control and therefore behave differently in response to the symptom experience. SM support 
focuses on enhancing a person’s perceived self-efficacy for symptom management through 
modifying how a person thinks, feels, motivates and performs in order to strengthen a person’s 
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symptom control.44  The findings of this study support Hoffman et al’s view that patients 
engage in a range of behaviors associated with CRF.  The scale developed in this study can 
potentially provide a useful tool for understanding patients’ self-efficacy in engaging in these 
behaviors, and in turn more effectively targeting of interventions. 
 
To the best of our knowledge, this study is the first to develop and pilot-test a tool for measuring 
components of fatigue SM specifically for patients with advanced cancer. Simultaneous with 
this study, Hoffman and colleagues developed an instrument known as Measurement of 
Perceived Self-efficacy for Fatigue Self-management (PSEFSM).45 Although both the 
PSEFSM and the SMSFS-A were based on similar theoretical premises, there are two major 
differences between the two instruments. Firstly, the PSEFSM is different to the SMSFS-A in 
that it measures perceived self-efficacy as an overall construct whereas the SMSFS-A depicts 
perceived self-efficacy as a construct consisting of a number of distinct behaviors used by the 
patient. Secondly, the SMSFS-A was specifically designed for patients with advanced cancer, 
whereas the PSEFSM was designed for patients with cancer in general. Advances in assessing 
fatigue SM are expected to enable the development of interventions to enhance patient 
perceived self-efficacy related to fatigue SM, and subsequently fatigue severity.45 
 
The SMSFS-A potentially provides a useful measure of SM in patients with advanced cancer 
for a symptom that is frequently occurring, persistent and severe. In the provision of fatigue 
SM support, health professionals ideally seek to understand the patient’s perspectives, rather 
than dictating behavioral changes.46, 47 To enable greater understanding of the complexity of 
SM behaviors in this population, further testing of factors associated with these fatigue SM 
components is required. Such investigations can inform the design of fatigue SM interventions. 
This instrument also has potential for use by clinical nurses undertaking collaborative care 
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planning with the patient. The understanding of whether certain behaviors are effective or 
ineffective (and if so, to what extent) and the patient’s perceived self-efficacy levels might 
prompt effective perceived self-efficacy enhancement interventions. In particular, resources 
could be directed to those behaviors that are recommended by evidence-based guidelines and 
behaviors that patients are not confident to use. 
 
The generalizability of the items of the SMSFS-A might be limited to a non-culturally diverse 
population. The sample of both the semi-structured interviews and the pilot test were all 
Caucasian Australians. The pilot test included patients who were attending treatments or 
receiving care at a tertiary cancer centre, with very low co-morbidity scores. These means that 
the items generated in this process may mean that further testings are required to ensure 
generalizability of the items. It also became apparent in the review process that the wording 
used might not be commonly used in countries other than Australia. Another limitation of this 
study is that reliability testing using Cronbach’s alpha and the construct validity of the SMSFS-
A could not be evaluated due to limited sample size. As discussed earlier, the SMSFS-A was 
developed to measure components of SM respective to distinct behaviors, rather than to 
measure outcomes as a single theoretical construct. Lastly, the SMSFS-A is lengthy, 
comprising 53 numerical rating scales for 17 items for distinct behaviors and two global items. 
The lengthiness of this tool might limit its use in routine clinical use. However, future work 
can determine if components of the tool can be reduced to allow for routine clinical use. 
 
Despite these limitations, the SMSFS-A usefully breaks down the assessment of SM 
components specific to the frequency and effectiveness of behaviors that patients use. In the 
collaborative planning process in SM models, the patient set goals together with the health 
professional in undertaking specific strategies. The SMSFS-A could potentially be useful in 
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this process, enabling health professionals to intervene to enhance patient efficacy and provide 
evidence-based information and skills training. Documentation of these outcomes also allows 
health professionals to evaluate previous interventions, facilitate a conversation and inform 
subsequent interventions. 
 
Conclusion 
Fatigue is a prevalent symptom in advanced cancer. Support for this distressing symptom can 
be informed by understanding the complexity of components of SM including the frequency, 
perceived effectiveness, and perceived self-efficacy of fatigue SM behaviors. Although this 
tool is not ready for routine use, this study provides preliminary results that demonstrate the 
potential of SMSFS-A for measuring SM concerning this population. 
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Table 1.Sample Characteristics of the Semi-structured Interviews (n=10) and the Pilot Test (n=10) 
Characteristics Phase I. 
Participants 
(n=10) 
Phase III 
Participants  
(n=10) 
Age (years)  
 
Median (Range) 
67 (44-81) 
M (SD) 
62.6 (9.10) 
Gender  
Male 
Female 
N (%) 
5 (50%) 
5 (50%) 
N (%) 
1 (10%) 
9 (90%) 
Ethnicity  
Caucasian 
African 
Asian 
Aboriginal/Torres Strait Islanders 
Others 
 
10 (100%) 
0 
0 
0 
0 
 
8 (80%) 
0 
1 (10%) 
0  
1 (10%) 
Education  
Completed primary schooling 
7-12 years 
Completed high school 
Post-secondary school 
Tertiary education 
 
3 (30%) 
2 (20%) 
3 (30%) 
0 (0%) 
2 (20%) 
 
1 (10%) 
2 (20%) 
3 (30%) 
4 (40%) 
0  
Living Arrangement  
Live with partner 
Live with other family member or friend 
Alone 
 
5(50%) 
2 (20%) 
3 (30%) 
 
5(50%) 
2 (20%) 
3 (30%) 
Income (per annum)  
<20,000 
20,001-30,000 
30,001-40,000 
40.001-50,000 
50,001-60,000 
>60,000 
 
7 (70%) 
3 (30%) 
0 
0 
0 
0 
 
4 (40%) 
4 (40%) 
0 
1 (10%) 
0 
1 (10%) 
Table(s)
2 
 
Marital status  
Married 
Divorce 
De fecto 
Widowed 
Single 
 
5 (50%) 
3 (30%) 
0 (0%) 
1 (10%) 
1 (10%) 
 
4 (50%) 
3 (30%) 
0 
2 (10%) 
1 (10%) 
Primary tumour site 
Lung 
Breast 
Colon 
Head and Neck 
Prostate 
Ovarian 
 
1 (10%) 
2 (20%) 
2 (20%) 
2 (20%) 
2 (20%) 
1 (10%) 
 
6 (60%) 
4 (40%) 
0 
0 
0 
0 
Current anti-cancer therapy  
Chemotherapy 
Radiotherapy and targeted therapy 
Chemotherapy and targeted therapy 
Targeted therapy only 
Not current anti-cancer therapy 
 
6 (60%) 
1 (10%) 
1 (10%) 
1 (10%) 
1 (10%) 
 
0  
3 (10%) 
1 (10%) 
1 (10%) 
5 (10%) 
  M (SD) 
Australian Karnofsky Performance Scale NC 74 (18.38) 
Fatigue NAS NC 5.6 (1.71) 
  Median (Range) 
Charlson Comorbidity Index:  NC 0 (0-6) 
Note. NC = Did not collect 
Table 2. Categories of Behaviors associated with Cancer-Related Fatigue 
Broader categories 
of behaviors 
Categories of 
behaviors 
Behaviors/ actions 
Cognitive Doing relaxing tasks/ 
Distraction 
 reading magazines 
 watching TV  
 reading 
 doing puzzles 
 reading newspaper 
Activity Exercise  walking 
 jogging 
 doing weights  
 participate in a walking program 
 Keeping busy  going to work  
 spending time with loved ones 
 spending time with friends 
 doing household chores 
 Managing workload  pacing oneself 
 taking breaks during a task  
 conserving energy for later tasks 
 Accepting help from 
others 
 delegating tasks 
 receiving home help service 
 sharing housework with family 
 accepting help from family 
 Rest  taking naps 
 sleeping 
 lying down 
 sitting 
Nutrition Optimising nutritional 
intake 
 taking nutritional supplement  
 maintaining healthy/ balanced diets 
Medication Managing medications  taking medications 
 taking pain relief to indirectly manage 
fatigue 
 reducing the dose of pain relief 
 
 
Table(s)
Table 3. Items (Behaviors) included in the Final SMSFS-A 
Fatigue Self-management Behaviors 
Activities 
Take short sleeps during the day (fall asleep for less than 3 hours) 
Rest during the day (without falling asleep) 
Do aerobic exercise (e.g. walking/ stair climbing/ swimming) 
Do stretching exercises 
Do strength exercises 
Delegate tasks to others 
Pace your activities throughout the day 
Do things to improve your sleep at night (e.g. reduce noise and light; avoid 
caffeine before bed) 
Complementary or alternative therapies 
Use complementary or alternative therapies (e.g. acupuncture/ aromatherapy/ 
massage/ reflexology) 
Cognitive 
Do things that distract you from our fatigue (e.g. hobbies/socialising) 
Plan your activities to make the most of your energy levels through the day 
Psychological 
Do relaxing things (e.g. music and reading) 
Talk to someone about your fears and concerns about fatigue 
Nutrition 
Eat a balanced diet 
Drink beverages with caffeine (e.g. coffee/tea/Coke/Red-Bull®) 
Drink nutritional supplements (e.g. high protein/ vitamin drinks) 
Overall 
Overall, over the past 7 days, how would you rate your effectiveness in 
relieving your fatigue? 
Overall, over the past 7 days, how would you rate your confidence in 
managing your fatigue? 
Note. The three domains of outcomes (Frequency of behavior use and perceived levels of 
effectiveness and self-efficacy) are assessed for all 17 behavior-specific items “over the past 
7 days”.  
 
Table(s)
Table 4. Sample Characteristics of the Pilot Test (n=10) 
Characteristics Participants 
(n=10) 
Gender  
Male 
Female 
N (%) 
1 (10%) 
9 (90%) 
Ethnicity 
Caucasian 
African 
Asian 
Aboriginal/Torres Strait Islanders 
Others 
 
8 (80%) 
0 
1 (10%) 
0  
1 (10%) 
Education 
Completed primary schooling 
7-12 years 
Completed high school 
Completed tertiary education 
 
1 (10%) 
2 (20%) 
3 (30%) 
4 (40%) 
Living Arrangement 
Live with partner 
Live with other family member or friend 
Alone 
 
5(50%) 
2 (20%) 
3 (30%) 
Income (per annum) 
<20,000 
20,001-30,000 
30,001-40,000 
40.001-50,000 
50,001-60,000 
>60,000 
 
4 (40%) 
4 (40%) 
0 
1 (10%) 
0 
1 (10%) 
Marital status 
Married 
Divorce 
Widowed 
Single 
 
4 (50%) 
3 (30%) 
2 (10%) 
1 (10%) 
Primary tumour site 
Lung 
Breast 
Colorectal 
Prostate 
 
6 (60%) 
4 (40%) 
0 
0 
Current anti-cancer therapy 
Chemotherapy 
Radiotherapy only 
Chemotherapy and radiotherapy 
Targeted therapy only 
Not current anti-cancer therapy 
 
0  
3 (10%) 
1 (10%) 
1 (10%) 
5 (10%) 
  
 M (SD) 
Age (years)  62.6 (9.10) 
Australian Karnofsky Performance Scale: Mean 74 (18.38) 
Fatigue NAS 5.6 (1.71) 
  
Table(s)
 Median (Range) 
Charlson Comorbidity Index:  0 (0-6) 
Note. NAS= Numeric Analogue Scale; M=Mean; SD=Standard Deviation. 
 Figure 1. Bland-Altman Plots (n=10) to establish the agreement between test-retest for the self-perceived overall 
effectiveness levels for fatigue self-management. The mean difference (solid line) and the limit of agreement 
(broken lines) are indicated. 
 
 
 
 
 
 
 
 
Figure
 Figure 2. Bland-Altman Plots (n=10) to establish the agreement between test-retest for the self-perceived overall 
self-efficacy levels for fatigue self-management. The mean difference (solid line) and the limit of agreement 
(broken lines) are indicated. 
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